Global Injectable Drug Delivery Market is Expected to Grow by CAGR 11.5% In The Forecast Period 2017 To 2024

Data Bridge Market Research new Insight’s on Global Injectable drug delivery market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.”Global Injectable Drug Delivery MarketAccess Full Report: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/

The market is segmented by Type (Devices (Conventional Injection Devices, Self Injection Devices),  Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

The actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024.

Recent Developments: Global Injectable Drug Delivery Market

The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. On the other hand, safety concerns regarding the use of injectables, increased risk of blood-borne infections due to injectables, and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.

Market Segmentation: Global Injectable Drug Delivery Market

  • The Global Injectable Drug Delivery Market is segmented on the basis of Type, Applications,Usage Pattern, Mode of Administration, End User and  Geography
  • Based on type, the global injectable drug delivery market is segmented into devices and formulations. In 2017, the market is expected to dominate by the formulations segment with highest market share and is also expected to grow at the highest CAGR in the forecasted period 2017 to 2024.
  • By product, the needle free injectors are further segmented into fillable needle-free injectors and prefilled needle-free injectors. On the basis of technology, the needle-free injectors market is further segmented into jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors.
  • By usability the needle free injector is segmented into disposable and reusable injectors. By product, the autoinjectors is further segmented into fillable needle-free injectors and prefilled needle-free injectors. On the basis of technology, the autoinjectors market is further segmented manual and automated autoinjectors.
  • By design, the auto injectors is segmented into standardized and customizable auto injectors. The pen injectors market is further classified based on number of cartridges into single chamber and dual chamber pen injectors. By design, the pen injectors market is segmented into standardized and customizable pen injectors.
  • On the basis of applications, the global Injectable drug delivery market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others. In 2017, the hormonal disorders applications segment is expected to dominate the market with highest market share. The autoimmune disease segment is further sub-segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
  • On the basis of usage pattern the global injectable drug delivery market is segmented into curative care, immunization, and others. In 2017, the curative care is expected to dominate the market with highest market share and is expected to continue the trend in the forecast period.
  • Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system. Administration through skin is the most common and the highest growing segment in the forecast period 2017 to 2024.
  • On the basis of end user the global injectable drug delivery market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies. Among these, in 2017 hospital segment dominated the market and the trend is expected to remain the same till 2024.

Geographic Segmentation: Global Injectable Drug Delivery Market

Based on geography the market is segmented into 5 geographical regions, North North America, Europe, Asia-Pacific, South America and Rest of the world. In 2017, North America is expected to account for the largest share of this market, followed by Europe. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

Company Share Analysis: Global Injectable Drug Delivery Market

The report also includes company’s share analysis for the major companies operating in this market by major regions as North America, Europe and Asia Pacific. The details of mergers and acquisitions, product launches, expansions, and product life cycle matrix are also a part of this report. Some of the major players operating in the Global Injectable drug delivery market are Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd. among others

The Injectable drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

Some of the major key players operating in the market are Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd.

Other Market Insights:

North America injectable drug delivery market is expected to reach USD 354.5 billion by 2024 from USD 154.0 billion in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024.

More Insights

Europe Injectable Drug Delivery Market is expected to reach USD 265.0 billion by 2024 from USD 107.4 billion in 2016, at a CAGR of 11.9 % in the forecast period 2017 to 2024.

More Insights